Genetic susceptibility to immune-related adverse events among melanoma patients treated with ipilimumab.

被引:0
|
作者
Pluta, John [1 ]
Qian, Lu [2 ]
D'Andrea, Kurt [1 ]
Duan, Chunzhe [3 ]
Weathers, Benita [1 ]
Wind-Rotolo, Megan [4 ]
Kanetsky, Peter [5 ]
Nathanson, Katherine [1 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Roche Holding AG, Shanghai, Peoples R China
[4] Bristol Myers Squib, New York, NY USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1352
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Immune-related Adverse Events in Cancer Patients
    Pallin, Daniel J.
    Baugh, Christopher W.
    Postow, Michael A.
    Caterino, Jeffrey M.
    Erickson, Timothy B.
    Lyman, Gary H.
    ACADEMIC EMERGENCY MEDICINE, 2018, 25 (07) : 819 - 827
  • [42] Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Liang, Yao
    Maeda, Osamu
    Ando, Yuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, : 365 - 375
  • [43] Immune-related adverse events in cancer patients being treated with immune checkpoint inhibitors
    Byrne, Margaret M.
    Lucas, Mathew
    Pai, Lori
    Breeze, Janis
    Parsons, Susan K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (06) : 650 - 657
  • [44] Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
    Cheema, Parneet K.
    Iafolla, Marco A. J.
    Abdel-Qadir, Husam
    Bellini, Andrew B.
    Chatur, Nazira
    Chandok, Natasha
    Comondore, Vikram R.
    Cunningham, Morven
    Halperin, Ilana
    Hu, Anne B.
    Jaskolka, Diana
    Darvish-Kazem, Saeed
    Khandaker, Masud H.
    Kitchlu, Abhijat
    Sachdeva, Jasdip S.
    Shapera, Shane
    Woolnough, Nicholas R. J.
    Nematollahi, Massey
    CURRENT ONCOLOGY, 2024, 31 (10) : 6356 - 6383
  • [45] Association between lactate dehydrogenase levels and immune-related adverse events among patients with melanoma on immune checkpoint inhibitors
    Pan, Catherina
    Lau, William
    Kim, Daniel
    Lau, Charles
    Rowley, Rachael
    Kanwar, Ruhi
    LeBoeuf, Nicole
    Nambudiri, Vinod
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB19 - AB19
  • [46] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (05) : 637 - 640
  • [47] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023,
  • [48] Development of endocrine immune-related adverse events and improved survival in advanced melanoma patients treated with nivolumab monotherapy
    Maeda, Takuya
    Yoshino, Koji
    Nagai, Kojiro
    Oaku, Satoe
    Kato, Megumi
    Hiura, Azusa
    Hata, Hiroo
    EUROPEAN JOURNAL OF CANCER, 2019, 115 : 13 - 16
  • [49] Immune-related adverse events in patients treated with immunotherapy according to corticosteroid exposure
    Meraz-Brenez, Andres
    Aranda-Gutierrez, Alejandro
    Jael Soliz, Dhylan
    Reyes-Vanegas, Diego
    Gonzalez-Sanchez, Hector Raul
    Martinez-Cannon, Bertha Alejandra
    Verduzco-Aguirre, Haydee Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Autoantibodies as potential biomarkers of immune-related adverse events in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors.
    Gandhi, Aesha
    Taylor, John
    Morici, Michael
    Reid, Anna
    Meniawy, Tarek
    Khattak, Muhammad Adnan
    Gray, Elin
    Millward, Michael
    Zaenker, Pauline
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)